United Therapeutics CEO Martine Rothblatt's 2021 pay falls 27% to $3.5M
United Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
United Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, four executives at United Therapeutics received on average a compensation package of $2.3M, a 46% decrease compared to previous year.
Average pay of disclosed executives at United Therapeutics
Martine Rothblatt, Chief Executive Officer, received $3.5M in total, which decreased by 27% compared to 2020. 61% of Rothblatt's compensation, or $2.1M, was in non-equity incentive plan. Rothblatt also received $1.4M in salary and $10K in other compensation.
For fiscal year 2021, the median employee pay was $189,023 at United Therapeutics. Therefore, the ratio of Martine Rothblatt's pay to the median employee pay was 19 to one.
Michael Benkowitz, Chief Operating Officer, received a compensation package of $2.3M, which decreased by 55% compared to previous year. 43% of the compensation package, or $1M, was in non-equity incentive plan.
James Edgemond, Chief Financial Officer, earned $1.9M in 2021, a 41% decrease compared to previous year.
Paul Mahon, General Counsel, received $1.7M in 2021, which decreases by 59% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2022.